BRCA2 and cancer: In contrast, a varied pattern was observed in BRCA2, with four out of the eight pathogenic variants being significantly more frequently detected in the regional cohort compared to the nationwide cancer cohort, and a similar tendency was observed for five of the 12 VUS variants.